These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 3400525

  • 41. Nocturnal penile tumescence monitoring: importance for the differential diagnosis of erectile impotence.
    Walsh JK, Ulett GA, O'Regan J.
    Mo Med; 1982 May; 79(5):276-8. PubMed ID: 7099132
    [No Abstract] [Full Text] [Related]

  • 42. Recording of penile tumescence and rigidity in impotence.
    Lin MC, Hsieh JT, Liu SB, Hsu T, Tsai TC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):503-7. PubMed ID: 2794951
    [Abstract] [Full Text] [Related]

  • 43. [Diagnosis and therapy of erectile dysfunction].
    Stief CG.
    Internist (Berl); 1993 Aug; 34(8):767-74. PubMed ID: 8375990
    [No Abstract] [Full Text] [Related]

  • 44. [Intracavernous injection of papaverine. Diagnostic value].
    Nguyen Hoang T, Guillé F, Dufeuil P, Lobel B.
    Ann Urol (Paris); 1988 Aug; 22(1):54-6. PubMed ID: 3369846
    [Abstract] [Full Text] [Related]

  • 45. Comparison of RigiScan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity.
    Allen RP, Smolev JK, Engel RM, Brendler CB.
    J Urol; 1993 May; 149(5 Pt 2):1265-8. PubMed ID: 8479011
    [Abstract] [Full Text] [Related]

  • 46. [Recording of nocturnal penile tumescence using the Rigiscan device].
    Słojewski M, Grabowski M, Sikorski A.
    Wiad Lek; 1997 May; 50(1-3):55-8. PubMed ID: 9297360
    [Abstract] [Full Text] [Related]

  • 47. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Plea for the use of facilitator drugs. 2. Diagnostic and therapeutic applications].
    Buvat J, Buvat-Herbaut M, Lemaire A, Marcolin G.
    J Urol (Paris); 1989 May; 95(2):89-96. PubMed ID: 2567319
    [No Abstract] [Full Text] [Related]

  • 48. Evaluation of erectile dysfunction with continuous monitoring of penile rigidity.
    Kaneko S, Bradley WE.
    J Urol; 1986 Nov; 136(5):1026-9. PubMed ID: 3773061
    [Abstract] [Full Text] [Related]

  • 49. Relationship between nocturnal penile tumescence parameters, International Index of Erectile Function symptom scores and sildenafil responses1This paper was presented at the 6th Congress of the International Society of Sexual and Impotence Research, Buenos Aires, Argentina, 17-21 October 2004.
    Murad Başar M, Tuğlu D, Yilmaz E, Başar H, Batislam E.
    Scand J Urol Nephrol; 2006 Nov; 40(6):506-10. PubMed ID: 17130103
    [Abstract] [Full Text] [Related]

  • 50. An attempt to standardize the pharmacological diagnostic screening of vasculogenic impotence with prostaglandin E1.
    McMahon CG.
    Int J Impot Res; 1995 Jun; 7(2):83-90. PubMed ID: 7496445
    [Abstract] [Full Text] [Related]

  • 51. Sildenafil improves nocturnal penile erections in organic impotence.
    Terradas C, Levalle O, Nagelberg A, Mormandi E.
    Int J Impot Res; 2001 Apr; 13(2):125-9. PubMed ID: 11426352
    [Abstract] [Full Text] [Related]

  • 52. [Significance of the penile pressure index and value of the papaverine mini-test (8 mg)].
    Virag R, Bouilly P, Daniel C.
    J Mal Vasc; 1987 Apr; 12(1):40-5. PubMed ID: 3559410
    [Abstract] [Full Text] [Related]

  • 53. [Importance of nocturnal penile tumescence (NPT) monitoring in the evaluation of erectile disorders].
    Liebrecht L, Zuckerman Z.
    Harefuah; 1993 Sep; 125(5-6):174-8. PubMed ID: 8225100
    [No Abstract] [Full Text] [Related]

  • 54. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H, Natsume O, Yamamoto M, Suemori T, Yamada K.
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [Abstract] [Full Text] [Related]

  • 55. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P, Seftel AD, Corty EW, Rutchik SD, Hampel N, Althof SE.
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [Abstract] [Full Text] [Related]

  • 56. Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting: outcomes of 18 consecutive patients.
    Vickers MA, De Nobrega AM, Dluhy RG.
    J Urol; 1993 May; 149(5 Pt 2):1258-61. PubMed ID: 8479009
    [Abstract] [Full Text] [Related]

  • 57. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E, Kobelinsky M, Khoury R, Sarkis P, Bouyer I, Dauphin A, Delmas V, Boccon-Gibod L.
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [Abstract] [Full Text] [Related]

  • 58. [Analysis of nocturnal penile tumescence with continuous monitoring of penile rigidity].
    Kaneko S, Mizunaga M, Miyata M, Yachiku S, Kurita T, Bradley WE.
    Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1889-95. PubMed ID: 2292823
    [Abstract] [Full Text] [Related]

  • 59. Theoretical and technical problems in the measurement of nocturnal penile tumescence for the differential diagnosis of impotence.
    Wasserman MD, Pollak CP, Spielman AJ, Weitzman ED.
    Psychosom Med; 1980 Nov; 42(6):575-85. PubMed ID: 7465743
    [Abstract] [Full Text] [Related]

  • 60. Intracavernous drug administration: its role in diagnosis and treatment of impotence.
    Lue TF.
    Semin Urol; 1990 May; 8(2):100-6. PubMed ID: 2191398
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.